Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.’s Net Profit Rose 163.6% in First Quarter of 2022

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (浙江莎普爱思药业股份有限公司) (603168.SH) reported a net profit of 27.7 million yuan in the first quarter of 2022, up 163.6% year-on-year.

Meanwhile, the company posted 149.4 million yuan in revenue, down 2.5% year-on-year.

At the end of the reporting period, it had 1.5 billion yuan in total assets and 160.8 million yuan in total liabilities, with a liability-to-asset ratio of 10.4%.